tau anticorps (pSer396)
-
- Antigène Voir toutes tau Anticorps
- tau (tau Protein)
-
Épitope
- pSer396
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp tau est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC)
- Attributs du produit
- Phosphorylated antibody
- Purification
- Affinity purification
- Immunogène
- A phospho specific peptide corresponding to residues surrounding S396 of human Tau
- Isotype
- IgG
- Top Product
- Discover our top product tau Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000 IHC 1:50-1:100
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- tau (tau Protein)
- Autre désignation
- Tau (tau Produits)
- Synonymes
- anticorps DDPAC, anticorps FTDP-17, anticorps MAPTL, anticorps MSTD, anticorps MTBT1, anticorps MTBT2, anticorps PPND, anticorps TAU, anticorps tau, anticorps PHF-tau, anticorps microtubule associated protein tau, anticorps MAPT
- Sujet
- This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.
- Poids moléculaire
-
Observed_MW: 50 kDa/60 kDa
Calculated_MW: 32-45 kDa/78- 80 kDa
- ID gène
- 4137
- UniProt
- P10636
-